Can Ventricular Resynchronization Reduce Atrial Fibrillation Recurrences?

  • M. G. Bongiorni
  • G. Giannola
  • E. Soldati
  • G. Arena
  • E. Hoffmann
  • M. Mariani
Conference paper


In recent years a new pacing therapy has been proposed for patients affected by heart failure (HF) in order to reduce inter- [1,2], intra- [3,4], and atrioventricular [5] (AV) dyssynchrony. Cardiac resynchronization therapy (CRT) has the goal of correcting these hemodynamic disorders, thus improving left ventricular (LV) performance. The benefits of CRT have been evaluated in a series of clinical trials [6-10].


Atrial Fibrillation Cardiac Resynchronization Therapy Atrial Pace Atrial Fibrillation Recurrence Sick Sinus Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wolferth CC, Margolies A (1935) Asynchronism in contraction of the ventricles in the so-called common type of bundle-branch block: its bearing on the determination of the side of the significant lesion and on the mechanism of split first and second heart sound. Am Heart J 10:425–452CrossRefGoogle Scholar
  2. 2.
    Haber E, Letham A (1965) Splitting of heart sounds from ventricular asynchrony in bundle branch block, ventricular ectopic beats and artificial pacing. Br Heart J 27:691–696PubMedCrossRefGoogle Scholar
  3. 3.
    Herman MV, Heinle RA, Klein MD, Gorlin R (1967) Localised disorders in myocardial contraction. Asynergy and its role in congestive heart failure. N Engl J Med 277:222232Google Scholar
  4. 4.
    Gibson DG, Greenbaum RA, Pridie RB, Yacoub MH (1988) Correction of left ventricular asynchrony by coronary artery surgery. Br Heart J 59:304–308PubMedCrossRefGoogle Scholar
  5. 5.
    Panidis IP, Ross J, Munley B, Nestico P, Mintz GS (1986) Diastolic mitral regurgitation in patients with atrioventricular conduction abnormalities: a common finding by Doppler echocardiography. J Am Coll Cardiol 7:768–774PubMedCrossRefGoogle Scholar
  6. 6.
    Leclercq C, Kass DA (2002) Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39:194–201PubMedCrossRefGoogle Scholar
  7. 7.
    Witte K, Thackray S, Clark A, Cooklin M, Cleland JGF (2000) Clinical trials update. IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II and APRICOT. Eur J Heart Fail 2:455–461PubMedCrossRefGoogle Scholar
  8. 8.
    Louis A, Cleland JGF, Crabbe S, Ford S, Thackray S, Houghton T et al (2001) Clinical trials update. CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2. RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the scientific sessions of the American College of Cardiology 2001. Eur J Heart Fail 3:381–387PubMedCrossRefGoogle Scholar
  9. 9.
    Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JGF (2001) Clinical trials update. Highlights of the scientific sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK CD, CHRISTMAS, OPTIME-CHE Eur J Heart Fail 3:491–494CrossRefGoogle Scholar
  10. 10.
    Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al (2000) The pacing therapies for congestive heart failure (PATH-CHF) study. Circulation 102 [Suppl 21:693 (abstract)Google Scholar
  11. 11.
    Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952PubMedCrossRefGoogle Scholar
  12. 12.
    Stevenson WG, Stevenson LW, Middlekauff HR et al (1996) Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 28:14581463Google Scholar
  13. 13.
    Kannel WB, Abbott RD, Savage DD (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022PubMedCrossRefGoogle Scholar
  14. 14.
    Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48PubMedCrossRefGoogle Scholar
  15. 15.
    Benjamin EJ, Levy D,Vaziri FM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. JAMA 271:840–844PubMedCrossRefGoogle Scholar
  16. 16.
    The CONSENSUS Trial Study Group (1987) Effect of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435CrossRefGoogle Scholar
  17. 17.
    Doval HC, Nul DR, Grancelli HO et al, for Grupo de Studio la Obrevida en la Insuficienca Cardiaca en Argentina (GESICA) (1994) Randomised trial of low dose amiodarone in severe congestive heart failure. Lancet 344:493–498Google Scholar
  18. 18.
    Pedersen OD, Bagger H, Keller N et al (2001) Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigation of Arrhythmia and Mortality ON Dofetilide (DIAMOND) substudy. Circulation 104:292–296PubMedCrossRefGoogle Scholar
  19. 19.
    Deedwania PC, Singh BN, Ellenbogen KA et al (1998) Spontaneous conversion and maintainance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observation from the Veterans Congestive Heart Failure Trial on Antiarrhythmic Therapy (CHF-STAT). Circulation 98:2574–2579PubMedCrossRefGoogle Scholar
  20. 20.
    Carson PE, Johnson DR, Dunkman WB et al (1993) The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. Circulation Suppl VL:VI 102–110Google Scholar
  21. 21.
    Dries DL, Exner DV, Gersh BJ et al (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD Trials. J Am Coll Cardiol 32:695–703PubMedCrossRefGoogle Scholar
  22. 22.
    Ehrlich JR, Nattel S, Hohnloser SH (2002) Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 13:399–405PubMedCrossRefGoogle Scholar
  23. 23.
    Leclerq C, Kass DA (2002) Retiming heart failure: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39:194–201CrossRefGoogle Scholar
  24. 24.
    Linde C, Leclercq C, Rex S et al (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40(1):111–118PubMedCrossRefGoogle Scholar
  25. 25.
    Etienne Y, Mansourati J, Gilard M et al (1999) Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillaiton. Am J Cardiol 83(7):1138–1140PubMedCrossRefGoogle Scholar
  26. 26.
    Saksena S, Prakash A, Hill M et al (1996) Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 28(3):687–694PubMedCrossRefGoogle Scholar
  27. 27.
    Katsivas A, Manolis A, Lazaris E et al (1998) Atrial septal pacing to synchronize atrial depolarisation in patients with delayed interatrial conduction. Pacing Clin Electrophysiol 21:2220–2225PubMedCrossRefGoogle Scholar
  28. 28.
    Spencer WH, Zhu DW, Markowitz T et al (1997) Atrial septal pacing: a method for pacing both atria simultaneously. Pacing Clin Electrophysiol 20:2739–2745PubMedCrossRefGoogle Scholar
  29. 29.
    Delfaut P, Saksena S, Prakash A, Krol RB (1998) Long term outcome of patients with drug refractory atrial flutter and fibrillation after single-and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 32(7):1900–1908PubMedCrossRefGoogle Scholar
  30. 30.
    Padeletti L, Porciani MC, Michelucci A et al (1999) Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Intery Card Electrophysiol 3:35–43CrossRefGoogle Scholar
  31. 31.
    Levy T, Walker S, Rochelle J, Paul V (1999) Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am J Cardiol 84:426–429PubMedCrossRefGoogle Scholar
  32. 32.
    Becker R, Klinkott R, Bauer A et al (2000) Multisite pacing for prevention of atrial tachyarrhythmias: potential mechanisms. J Am Coll Cardiol 35:1939–1946PubMedCrossRefGoogle Scholar
  33. 33.
    Garrigue S, Barold SS, Cazeau S, Gencel L, Jaïs P, Haissaguerre M (1998) Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol 21:1751–1759PubMedCrossRefGoogle Scholar
  34. 34.
    Blommaert D, Gonzalez M, Macumbitsi J et al (2000) Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol 35:1411–1415PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • M. G. Bongiorni
    • 1
  • G. Giannola
    • 2
  • E. Soldati
    • 1
  • G. Arena
    • 1
  • E. Hoffmann
    • 2
  • M. Mariani
    • 1
  1. 1.Cardiothoracic Department, Cisanello HospitalUniversity of PisaItaly
  2. 2.Division of Cardiology, Polyclinic HospitalUniversity of PalermoItaly

Personalised recommendations